Profile data is unavailable for this security.
About the company
Devonian Health Group Inc. is a Canada-based late-stage botanical pharmaceutical company. The Company's main activity is the development of botanical drugs from plant materials and algae for the treatment of inflammatory-autoimmune diseases, including ulcerative colitis and atopic dermatitis. It is also involved in the development of value-added products for dermo-cosmetics and the distribution of pharmaceutical products through its subsidiary. The Company’s flagship product, Thykamine, the pharmaceutical product issued from its SUPREX platform, is a product for the prevention and treatment of health conditions related to inflammation and oxidative stress. The Company’s flagship product, Thykamine, the pharmaceutical product issued from its SUPREX platform, is a product for the prevention and treatment of health conditions related to inflammation and oxidative stress. The Company's cosmeceutical products include R-Spinasome and Purgenesis.
- Revenue in CAD (TTM)5.03m
- Net income in CAD-4.28m
- Incorporated2017
- Employees6.00
- LocationDevonian Health Group Inc360 rue des EntrepreneursMONTMAGNY G5V 4T1CanadaCAN
- Phone+1 (514) 248-7509
- Fax+1 (450) 937-6696
- Websitehttps://groupedevonian.com/